Subclinical herpes virus reactivation and latency

Current Opinion in Infectious Diseases

Volumn 11, Issue 1, 1998, Pages 31-35

  Patel, Raj ^a,d   Harper, David R ^b,c  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES VIRUS; HUMAN; REVIEW; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSCRIPTION;

EID: 0031974793     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199802000-00008     Document Type: Review

References (54)

1. Podlech J, Hengerer F, Fleck M, Kunkel J, Flak D. Localization of latency-associated transcripts in the uterovaginal plexus of herpes simplex virus type 1 and 2 latently infected mice. J Gen Virol 1997; 78:1103-1108.
2. Obara Y, Furuta Y, Takasu T, Suzuki S, Susuki H, Matsukawa S, et al. Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization. J Med Virol 1997; 52:136-142.
3. Yoshikawa T, Stanberry LR, Bourne N, Krause PR. Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latency. J Virol 1996; 70:1535-1541.
4. Gesser RM, Koo SC. Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. J Virol 1997; 71:4103-4106.
5. Suzuki S. Detection of latent herpes simplex virus in human vestibular ganglia. Hokkaido lgaku Zasshi, Hokkaido J Med Sci 1996; 71:561-571.
6. Bruni R, Roizman B. Open reading frame P-a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA. Proc Natl Acad Sci USA 1996; 93:10423-10427.
7. Kesari S, Lee VM, Brown SM, Trojanowski JQ, Fraser NW. Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus 1. J Neurosci 1996; 16:5644-5653.
8. Lachmann RH, Brown C, Efstathiou S. A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection. J Gen Virol 1996; 77:2575-2582.
9. Makarova O, Gorneve G, Wu F, Farutin V, Villeponteau B, Poliani L, et al. Incorporation of nuclear matrix attachment regions into the herpes simplex virus type genome does not include long-term expression of a foreign gene during latency. Gene Ther 1996; 3:829-833.
10. Nichol PF, Chang JY, Johnson EM Jr, Olivo PD. Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways. J Virol 1996; 70:5476-5485.
11. Sawtell NM. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol 1997; 71:5423-5431.
12. Maggioncalda J, Mehta A, Su YH, Fraser NW, Block TM. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology 1996; 225:72-81.
13. Field HJ, De Clercq E. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment and maintenance of latent herpes virus infection in mice. J Gen Virol 1981; 56:259-265.
14. Thackray AM, Field HJ. Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model. Antimicrob Agents Chemother 1996; 40:846-851.
15. Thackray AM, Field HJ. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency. J Infect Dis 1996; 173:291-299.
16. Field HJ, Efstathiou S, Thackery AM. A quantitative study of neuronal latency following the administration of famciclovir or valaciclovir to HSV-1-infected mice. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 28 September-1 October 1997; Toronto, Canada.
17. Thackray AM, Field HJ. Further investigation into the recurrence of infectious virus in the nervous system of mice infected with HSV-1 on cessation of valaciclovir therapy [abstract]. Antiviral Res 1997; 34:81A.
18. Wu TT, Su YH, Block TM, Taylor JM. Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J Virol 1996; 70:5962-5967.
19. Zabolotny JM, Krummenacher C, Fraser NW. The herpes simplex virus type 1 2.0-kilobase latency-associated transcript is a stable intron which branches at a guanosine. J Virol 1997; 71:4199-4208.
20. Goldenberg D, Mador N, Ball MJ, Panet A, Steiner I. The abundant latency-associated transcripts of herpes simplex virus type 1 are bound to polyribosomes in cultured neuronal cells and during latent infection in mouse trigeminal ganglia. J Virol 1997; 71:2897-2904.
21. Wilcox CL, Smith RI, Everett RD, Mysofski D. The herpes simplex virus type 1 immediate-early protein ICPO is necessary for the efficient establishment of latent infection. J Virol 1997; 71:6777-6785.
22. Thompson RI, Sawtell NM. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol 1997; 71:5432-5440.
23. Chen SH, Kramer MF, Schaffer PA, Coen DM. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J Virol 1997; 71:5878-5884.
24. Garber DA, Schaffer PA, Knipe DM. A LAT associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol 1997; 71:5885-5893.
25. Cohen J, Perng GC, Drolet BS, Yukht A, Slanina SM, Ghiasi H, et al. Deletion of HSV-1 LAT nucleotides 660 to 1499 significantly decreases in vivo spontaneous reactivation. Proceedings of the 22nd International Herpesvirus Workshop; 2-8 August 1997; San Diego, California, 1997. 336A.
26. Wechsler SL, Drolet BS, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, Perng GC. The spontaneous reactivation function of the HSV-1 LAT gene resides completely within the first 811 nucleotides of the 8.3 kb primary LAT transcript. Proceedings of the 22nd International Herpesvirus Workshop; 2-8 August 1997; San Diego, California, 1997. 325A.
27. Frazier DP, Cox D, Godshalk EM, Schaffer PA. The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells. J Virol 1996; 70:7424-7432.
28. Frazier DP, Cox D, Godshalk EM, Schaffer PA. Identification of cisacting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells. J Virol 1996; 70:7433-7444.
29. Kenny JJ, Millhouse S, Wotring M, Wigdahl B. Upstream stimulatory factor family binds to the herpes simplex virus type 1 latency-associated transcript promoter. Virology 1997; 230:381-391.
30. Tatarowicz WA, Martin CE, Pekosz AS, Rauscher FJ III, Chiang SY, Beerman TA, Fraser NW. Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J Neurovirol 1997; 3:212-224.
31. Carpenter DE, Stevens JG. Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome. Human Gene Ther 1996; 7:1447-1454.
32. Halford WP, Gebhardt BM, Carr DJ. Mechanisms of herpes simplex virus type reactivation. J Virol 1996; 70:5051-5060.
33. Tal-Singer R, Lasner TM, Podrzucki W, Skokotas A, Leary JJ, Berger SL, Fraser NW. Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol 1997; 71:5268-5276.
34. O'Brien WJ, Tsao LS, Taylor JL. Tissue specific expression of LATS in HSV-1 latency infection rabbits. Proceedings of the 22nd International Herpesvirus Workshop; 2-8 August 1997; San Diego, California; 1997. 340A.
35. Skokotas A, Fraser N. Cell factor binding to the TK Gene promoter at latency and reactivation. Proceedings of the 22nd International Herpesvirus Workshop; 2-8 August 1997; San Diego, California; 1997. 351A.
36. Koutsky LA, Stevens CE, Holmes KK, Ashley RL, Kiviat NB, Critchlow CW, Cory L. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992; 326:1533-1539.
37. Straus SE, Rooney JF, Hallahan C. Acyclovir suppresses subclinical shedding of herpes simplex virus [letter]. Ann Intern Med 1996; 125:776.
38. Barton SE, Davis JM, Moss VW, Tyms AS, Munday PE. Asymptomatic shedding and subsequent transmission of genital herpes simplex virus. Genitourinary Med 1987; 63:102-105.
39. Rooney JF, Felser JM, Ostrove JM, Straus SE. Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med 1986; 314:1561-1564.
40. Moore DE, Ashley RL, Zarutskie PW, Coombs RW, Soules MR, Corey L. Transmission of genital herpes by donor insemination. J Am Med Assoc 1989; 261:3441-3443.
41. Mertz GI, Bernadetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.
42. Brown ZA, Bernadetti J, Ashley R, Burchett S, Selke S, Berry S, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labour. N Engl J Med 1991; 324:1247-1252.
43. Arvin AM, Hensleigh PA, Prober CG, Au DS, Yasukawa LL, Wittek AE, et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986; 315:796-800.
44. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 1997; 99:1092-1097.
45. Wald A. Subclinical shedding of herpes simplex virus in the genital tract: implications for transmission. Herpes J 1997; 4:30-35.
46. Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992; 116:433-437.
47. Wald A, Seh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infection. N Engl J Med 1995; 333:770-775.
48. Wald A, Taylor L, Warren T, Corey L. Subclinical shedding of herpes simplex virus in men with genital herpes [abstract]. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, USA, 1995; Am Soc Microb 1995.
49. Wald A, Taylor L, Warren T, Corey L. Subclinical shedding of herpes simplex virus in men with genital herpes [abstract]. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, USA, 1995; Am Soc Microb 1995.
50. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124:8-15.
51. Straus SE, Seidin M, Takiff HE, Rooney JF, Felser JM, Smith HA, et al. Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes. Sex Transm Dis 1989; 16:107-113.
52. Sacks SI, Hughes A, Renneie B, Boon R. Famciclovir for suppression of asymptomatic and symptomatic recurrent genital herpes shedding: a randomized double-blind, double-dummy, parallel-group, placebo controlled trial; Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. 28th September-1st October 1997, Toronto, Canada.
53. Patel R, Cowan FM, Barton SE. Advising patients with genital herpes - aciclovir reduces asymptomatic viral shedding, but effect on transmission is unclear. BMJ 1997; 314:85-86.
54. Barton SE, Munday PE, Patel RJ. Asymptomatic shedding of herpes simplex virus from the genital tract: uncertainty and its consequences for patient management, Int J STD AIDS 1996; 7:229-232.